GOT2 and prostate cancer: Our exploration indicated that most tyrosine metabolism-related enzymes, including TAT, HPD, DDC, GOT1, COMT, GSTZ1, LCMT1, and FAH, were significantly upregulated, while GOT2 and ADH5 were significantly deregulated in prostate cancer samples.